Proteinolipopolysaccharide (PLPS) from Yersinia pseudotuberculosis acts as a protective antigen, significantly enhancing survival rates in animal models. This antigen stimulates key immune responses, highlighting its potential for developing new vaccines against pseudotuberculosis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: